Imedex E-learning (audio)

Combination of Novel Agents: Is this the Final Answer? - John N. Allan, MD

Informações:

Sinopsis

Positioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease